Microbot Medical (NASDAQ: MBOT) — Perfil da empresa, notícias e dados financeiros
Microbot Medical focuses on robotic technologies to enhance minimally invasive surgeries and improve patient outcomes.
Microbot Medical
Microbot Medical (NASDAQ:MBOT) is a pioneering company focused on the design and development of robotic technologies aimed at advancing minimally invasive surgeries. Their operations span across creating innovative solutions that could drastically improve surgical outcomes and patient recovery times. Microbot Medical's projects are largely centered around their proprietary technology platforms, which include micro-robotics, with the aim of addressing unmet needs in medical procedures. These endeavors are aligned with their objectives to enhance surgical precision, reduce risks associated with traditional surgical methods, and ultimately improve the quality of life for patients. The company's commitment to research and development in the medical field showcases its dedication to pushing the boundaries of medical science and technology.
Resumo
Operações
Produtos e/ou serviços de Microbot Medical
- LIBERTY® Robotic Surgical System: This is the core product of Microbot Medical. It's a single-use endovascular robotic system designed for minimally invasive therapy delivery directly on the heart surface.
- Minimally Invasive Therapy Delivery: The LIBERTY® system allows for the delivery of various therapeutic interventions directly to the heart surface or within other vascular structures, such as ablation for atrial fibrillation or targeted drug delivery.
- Endovascular Robotic Surgery: Microbot Medical's technology aims to revolutionize endovascular procedures through the LIBERTY® system, offering greater precision, reduced radiation exposure, and improved accessibility compared to traditional methods.
- Remote-Controlled Surgery: The LIBERTY® system can be controlled remotely by a surgeon, potentially enabling tele-surgery and improved access to specialized care.
- Clinical Development and Regulatory Affairs: Microbot Medical is actively involved in the clinical development and regulatory approval process for the LIBERTY® system, working towards obtaining FDA clearance for its use in human patients.
- Partnerships and Collaborations: Microbot Medical collaborates with leading medical institutions and organizations to advance the development and evaluation of the LIBERTY® system, fostering innovation and expanding its reach.
equipe executiva do Microbot Medical
- Harel GadotCo-Founder, President, CEO & Chairman
- Rachel VakninChief Financial Officer
- Simon SharonCTO & GM of Microbot Israel
- Juan Diaz-CartelleChief Medical Officer
- Christina BaileyVice President of Sales
- Allison RosefortVice President of Marketing
- Naama MoavVice President of Human Resources
- Michael LytleHead of Sales Operations & Analytics
Principais indicadores financeiros
Resultados divulgados pela Microbot Medical, em USD.
- Cap. de mercado
- 75,2 mi
- Receita (TTM)
- 346 mil
- P/L
- —
- LPA (diluído, TTM)
- -0.3
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -14,7 mi | -13,1 mi | |
| 0 | -11,6 mi | -11,4 mi | |
| 0 | -9,9 mi | -10,7 mi | |
| 0 | -13,3 mi | -13,2 mi |